Related references
Note: Only part of the references are listed.17-DMAG targets the nuclear factor-κB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
Erin Hertlein et al.
BLOOD (2010)
Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tumors
Ramesh K. Ramanathan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia
Andrea G. S. Buggins et al.
LEUKEMIA RESEARCH (2010)
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
Chris Pepper et al.
BLOOD (2008)
The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Saman Hewamana et al.
BLOOD (2008)
A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
Elisabeth I. Heath et al.
CLINICAL CANCER RESEARCH (2008)
Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex
Dimitrios J. Stravopodis et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells
RR Furman et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
